AxoGen Newsroom

CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $17

Moomoo NewsNov 8 09:31 ET

JMP Securities Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsNov 8 01:31 ET

Raymond James Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $18

Moomoo NewsNov 7 14:31 ET

Axogen Analyst Ratings

BenzingaAug 9 07:04 ET

Buy Rating Affirmed for AxoGen: Strong Q2 Performance and Strategic Leadership Amidst Market Growth Potential

TipRanksAug 9 00:59 ET

Axogen Analyst Ratings

BenzingaJul 1 06:09 ET

Raymond James Initiates Coverage On Axogen With Outperform Rating, Announces Price Target of $13

BenzingaJul 1 06:09 ET

Axogen Analyst Ratings

BenzingaJun 20 12:10 ET

Buy Rating Upheld for AxoGen Amid Strong Financials and Innovative Growth Strategy

TipRanksMay 9 01:11 ET

Axogen's Strong Growth Prospects and Positive Analyst Outlook Prompt Buy Rating and Increased Price Target

TipRanksMar 6 23:20 ET

Buy Rating Affirmed: AxoGen's Robust Growth and Market Potential Drive Positive Outlook

TipRanksMar 6 00:45 ET

Buy Rating Affirmed for AxoGen on Strong Clinical Results and Encouraging Sales Performance

TipRanksJan 22 15:17 ET

Axogen Analyst Ratings

BenzingaJan 19 09:23 ET

Analysts Offer Insights on Healthcare Companies: ScPharmaceuticals (SCPH), Alnylam Pharma (ALNY) and AxoGen (AXGN)

TipRanksJan 9 01:10 ET

Buy Rating Affirmed for AxoGen on Strong Growth and Promising Market Prospects

TipRanksJan 5 10:46 ET

Canaccord Genuity Reiterates Buy on Axogen, Maintains $11 Price Target

BenzingaDec 7, 2023 10:44 ET

Axogen Analyst Ratings

BenzingaDec 7, 2023 10:43 ET

Buoyant AxoGen Performance and Growth Prospects: A Buy Recommendation Analysis

TipRanksNov 8, 2023 01:12 ET

Leerink Partners Initiates Coverage On Axogen With Outperform Rating, Announces Price Target of $9

BenzingaOct 16, 2023 11:37 ET

Axogen Analyst Ratings

BenzingaOct 16, 2023 11:35 ET